GranuFlo and NaturaLyte, both products manufactured by Fresenius and used in kidney dialysis procedures, have been linked to serious blood irregularity side effects. The numerous product liability lawsuits filed against the manufacturer were recently consolidated in Multidistrict Litigation in Massachusetts to resolve common questions of fact. Metabolic Alkalosis Injuries Being Investigated Lawsuits filed against manufacturer Fresenius and now part of the MDL (In Re: Fresenius GranuFlo/NaturaLyte Dialystate Products Liability Litigation) under the Honorable Douglas P. Woodlock in the District Court… Read More
Category: <span>Granuflo and NaturaLyte</span>
A newly widowed woman has filed a wrongful death lawsuit against Fresenius Medical Care North America alleging that her late husband suffered a heart attack and died following hemodialysis treatment using GranuFlo – a liquid given to dialysis patients to replace amino acids that are lost during the hemodialysis process. This widow’s story is becoming all too common. Thousands Report Serious GranuFlo / NaturaLyte Injuries According to a recent report in the Wall Street Journal, thousands of people have reported… Read More
More and more product liability lawsuits are being filed against GranuFlo and NaturaLyte manufacturer, Fresenius, as patients subjected to these dangerous dialysate solutions used in kidney dialysis machines are being injured – or dying. A South Carolina son whose father died during a routine kidney dialysis session in which GranuFlo was used has filed the latest GranuFlo lawsuit. Latest GranuFlo Lawsuit The GranuFlo drug injury lawsuit was filed by Clarence Lee Dubose, Jr., of South Carolina against Fresenius Medical Care… Read More
Millions of Americans undergo kidney dialysis, or hemodialysis, every day. While the procedure may be time consuming; it is generally thought to be safe. Until now. GranuFlo and NaturaLyte, two dialysate chemical solutions used in thousands of kidney dialysis centers, have been linked to metabolic alkalosis – a condition associated with low blood pressure, cardiac arrhythmia, heart attack, cardiac arrest and other cardiovascular problems. Nearly 1,000 incidents of cardiac arrests may be linked to these chemicals and the lawsuits filed… Read More
A widow in Ohio filed a wrongful death lawsuit in November alleging that her husband’s fatal heart attack during kidney dialysis treatment was caused by Fresenius Medical Care’s failure to provide adequate warnings about the side effects of Granuflo, a dialysis product. As a product liability attorney who is investigating claims of serious and fatal side effects caused by Fresenius dialysis products, the story of Deborah and Charles Swigert is painfully familiar to the stories I hear. The death of… Read More
Patients undergoing kidney dialysis should not have to wonder whether the medications they are receiving are safe. But an FDA investigation of one of the largest operators of dialysis centers and a major supplier of dialysis products raises serious safety concerns. This year, the FDA issued a Class I recall of dialysis drugs Granuflo and NaturaLyte acid concentrate manufactured by Fresenius Medical Care North America. Class I recalls are the most serious type of product recall. They involve situations in… Read More
